drugset / Trial / NCT02995473

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

NCT02995473 ↗

Phase 2 Completed 61 enrolled Galderma R&D
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is to evaluate the efficacy and safety of topical application of NP000888 ointment compared to vehicle in plaque and fingernail psoriasis subjects. Duration of administration: 24 weeks

Timeline

Start
2017-02-08
Primary completion
2018-05-03
Completion
2018-05-28

Drugs

EvaluationDrugModalityDoseRoute
Subject NP000888 Unknown 270 unknown Topical

Indications